-71%

est. 2Y upside i

HealthcareSeries A

Modern health insurance for dual income families

Rank

#1663

Sector

Healthcare IT

Est. Liquidity

~6Y

Data Quality

Data: Medium

Healia presents a moderate upside opportunity driven by its innovative solution in a large, underserved market and strong early customer traction (50+ customers, 40k employees using product).

Last updated: March 10, 2026

Bull (21%)+300%

Healia's novel 'Total Care Option' gains significant traction, expanding rapidly beyond its initial 50+ customers to capture a substantial share of the $126.2B SAM. The AI-powered platform becomes a dominant solution for dual-income families, driving ARR to over $50M by 2028 and justifying a $100M+ valuation at a premium multiple, leading to a successful acquisition or IPO.

Base (46%)+50%

Healia continues to grow steadily within its niche, expanding its customer base and refining its platform. While facing ongoing competition and regulatory hurdles, it achieves moderate market penetration, reaching an ARR of $5M-$10M by 2028 and supporting a valuation of $35M-$40M, offering a modest return for early equity holders.

Bear (33%)-80%

Dominant health insurance incumbents or large benefits administrators launch competing AI-powered solutions, leveraging their existing market share and resources. Healia struggles to differentiate and scale, leading to slower-than-expected growth, increased burn, and a down round or unfavorable exit that significantly erodes common stock value, potentially valuing the company below $10M.

Est. time to liquidity~6.0 years

Preference Stack Risk

high

Investors hold approximately $4.04M in liquidation preferences ahead of common stock, representing about 16.16% of the estimated $25M post-money valuation.

Dilution Risk

high

As an early-stage company, Healia will likely require several more funding rounds, leading to significant future dilution for current equity holders.

Secondary Liquidity

none

There is currently no active secondary market or tender offers for Healia's shares, limiting immediate liquidity options for employees.

Questions to Ask at the Interview

Strategic questions based on Healia's data — designed to show you've done your homework.

  • 1

    Given the 'medium' incumbent threat and the potential for large health insurance companies to develop similar solutions, what is Healia's long-term strategy to maintain its competitive moat and differentiate its 'Total Care Option'?

  • 2

    With 50+ customers and 40,000 employees using the product, how does Healia plan to scale its ARR significantly beyond $206,000 in the next 2-3 years, and what are the key metrics you're tracking for revenue growth?

  • 3

    As an early-stage company with $4.04M in funding, how does Healia envision its future funding rounds and potential liquidity events, and what is the expected timeline for employees to realize value from their equity?

Community

Valuation Sentiment

Our model estimates -71% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.